Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Piperazine | HCID 4837 | — |
| Reactant | Hexahydro-1,4-diazepine | HCID 68163 | — |
| Reactant | HCID 20382069 | HCID 20382069 | — |
| Solvent | Formic Acid | HCID 284 | — |
| Solvent | Formaldehyde | HCID 712 | — |
| Solvent | Methanol | HCID 887 | — |
| Product | HCID 20382060 | HCID 20382060 | — |
Reaction Steps
By substituting 30 g of hexahydro-1H-1,4-diazepine for the piperazine in Example 1, the product is 4-(hexahydro-1H-1,4-diazepin-1-yl)-3-phenoxy pyridine, bp 143°-145° C./0.13 mm). Three and four tenths g of this material is dissolved in a mixture of 4.5 g 37% formalin and 2 ml of methanol and is treated with 6 g of 97-100% formic acid. The mixture is heated at 100° C. for 18 hours. The mixture is cooled, treated with an excess of dilute hydrochloric acid and concentrated in vacuo. The residue is shaken with 100 ml of toluene and excess dilute aqueous sodium hydroxide. The organic phase is dried, concentrated and distilled to give 4-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-3-phenoxypyridine; bp 130°-131° C./0.1 mm.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04179563 |
|---|
| Source dataset | uspto-grants-1979_12 |
|---|
| ORD ID | ord-2961c5e597154513b07b3964c153169a |
|---|
| Source note | uspto-grants-1979_12 |
|---|